Fingers point at Baxter over Croatian dialysis deaths
This article was originally published in Clinica
Executive Summary
Baxter Healthcare has found itself immersed again in a second major haemodialysis scare in as many months, with the death last week of 23 renal patients undergoing treatment in several Croatian hospitals. No conclusive proof of cause had been established by October 15, but use of dialysers manufactured by the US multinational appeared to be the common link in the deaths.
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.